Deepak Chadha - Jan 24, 2023 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc. (FRTX)

Role
Chief R&D Officer and COO
Signature
/s/ Christine G. Long, Attorney-in-Fact for Deepak Chadha (power of attorney previously filed)
Stock symbol
FRTX
Transactions as of
Jan 24, 2023
Transactions value $
$0
Form type
4
Date filed
1/26/2023, 05:48 PM
Previous filing
May 9, 2022
Next filing
Dec 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FRTX Restricted Stock Units Award $0 +35K $0.00 35K Jan 24, 2023 Common Stock 35K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of issuer common stock upon settlement.
F2 The restricted stock units vest in full on the first anniversary of the grant date.